Gallbladder In the SCALE-trial, high-dose liraglutide for the treatment of obesity was associated with an increased risk of gallbladder events compared to placebo (2.5% versus 1.0% of patients, respectively) (84)
mean increases in resting heart rate of 1 to 4 beats per minute (bpm) were seen with routine clinical monitoring in semaglutide-treated patients vs
Are there contraindications I should know about
Despite this activity, GSPT1 degradation represents a promising potential therapeutic strategy, since GSPT1 dysregulation or increased expression is associated with multiple cancers
New Insights and Promising Therapies Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials Effects of GLP-1 on ovarian dysfunction in polycystic ovary syndrome: A protocol for systematic review and meta-analysis These weight loss injections work by mimicking a hormone that regulates appetite and food intake
4,21 There is also evidence to suggest GLP-1RAs can reduce motility in the small intestine
